Malady Kyle sold $55K of VZ
Malady Kyle (EVP and Group CEO-VZ Business) sold 1,100 shares of VERIZON COMMUNICATIONS INC (VZ) at $49.98 on 2026-09-08 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The sale represents a routine liquidity event for the executive and does not alter Verizon's fundamentals.
Market read
Minor insider sell; low trading relevance for most market participants.
What to watch
Potential tax planning or portfolio rebalancing; not necessarily a signal of company performance.
Background
Form 4 filings disclose insider transactions; a 10b5‑1 plan sale is pre‑arranged and not indicative of new information.
Ticker impact
SEC Form 4 shows EVP Kyle Malady sold 1,100 Verizon shares for $54,978 on 2026-09-08 via a 10b5‑1 plan.
No significant impact; price may stay flat or dip slightly.
Sale size is small relative to Verizon's market cap and insider ownership; typical for 10b5‑1 plans.
Market effects
Telecom sector sees no broader impact from this isolated insider sale.
U.S. market unaffected; Verizon remains a large‑cap holding.
Limited; only relevant to investors tracking Verizon insider activity.
Counterpoint
If insiders are reducing exposure, it could hint at upcoming challenges, but evidence is weak.
Key entities
- companyVerizon Communications Inc.
US telecom giant (ticker VZ).
- personKyle Malady
Executive Vice President and Group CEO of Verizon Business.


